First Manhattan’s GenMark Diagnostics, Inc GNMK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-1,000
| Closed | -$23K | – | 1674 |
|
|
2021
Q1 | $23K | Hold |
1,000
| – | – | ﹤0.01% | 1116 |
|
|
2020
Q4 | $14K | Hold |
1,000
| – | – | ﹤0.01% | 1112 |
|
|
2020
Q3 | $14K | Hold |
1,000
| – | – | ﹤0.01% | 1084 |
|
|
2020
Q2 | $14K | Sell |
1,000
-1,000
| -50% | -$10.2K | ﹤0.01% | 1111 |
|
|
2020
Q1 | $8K | Hold |
2,000
| – | – | ﹤0.01% | 1186 |
|
|
2019
Q4 | $9K | Hold |
2,000
| – | – | ﹤0.01% | 1162 |
|
|
2019
Q3 | $12K | Hold |
2,000
| – | – | ﹤0.01% | 1139 |
|
|
2019
Q2 | $12K | Hold |
2,000
| – | – | ﹤0.01% | 1166 |
|
|
2019
Q1 | $14K | Hold |
2,000
| – | – | ﹤0.01% | 1168 |
|
|
2018
Q4 | $9K | Hold |
2,000
| – | – | ﹤0.01% | 1183 |
|
|
2018
Q3 | $14K | Hold |
2,000
| – | – | ﹤0.01% | 1183 |
|
|
2018
Q2 | $12K | Hold |
2,000
| – | – | ﹤0.01% | 1175 |
|
|
2018
Q1 | $10K | Buy |
+2,000
| New | +$9.94K | ﹤0.01% | 1196 |
|
First Manhattan's GNMK Position: Q2 2021 in Review
First Manhattan sold out of GenMark Diagnostics, Inc (GNMK) in Q2 2021, closing a stake of 1,000 shares — an estimated $23K sold.
First Manhattan first reported a position in GNMK in Q1 2018 and held it in 13 quarters. The position peaked at $23K in Q1 2021. 0 funds tracked by Wall St. Rank hold GNMK as of Q2 2021.
- First Manhattan reported no remaining GenMark Diagnostics, Inc position as of Q2 2021 after selling out during the quarter.
- First Manhattan sold 1,000 GenMark Diagnostics, Inc shares in Q2 2021, an estimated $23K.
- First Manhattan first reported a position in GenMark Diagnostics, Inc in Q1 2018 and held it in 13 quarters.
- First Manhattan's GenMark Diagnostics, Inc position peaked at $23K in Q1 2021.
- 0 funds tracked by Wall St. Rank held GenMark Diagnostics, Inc as of Q2 2021.
Based on First Manhattan's 13F filing for Q2 2021, filed 16 Aug 2021.